Search Results
Nov 26, 2025, 05:28 ET Il Gruppo Menarini annuncia che, al 67° Congresso Annuale dell'American Society of Hematology, presenterà nuovi dati su ELZONRIS® (tagraxofusp-erzs)
oggi la presentazione di nuovi dati relativi a ELZONRIS® (tagraxofusp-erzs) in occasione dell Congresso annuale dell'American Society of Hematology (ASH), che si terrà a Orlando dal 6 al 9 dicembre.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 20:00 ET Central Point School District 6 Notifies Community of Data Security Incident
institution.For More InformationIndividuals seeking additional information may contact the District at:541.494.6200300 Ash StreetCentral Point, OR 97502The District regrets any concern this incident may cause and remains committed to safeguarding the personal
More news about: Central Point School District 6
Nov 25, 2025, 16:38 ET Bears Ears Inter-Tribal Coalition Recognized with Honors from Harvard's Honoring Nations Awards
country.The Honoring Nations award is the premier national recognition of Tribal governance excellence, administered by the Harvard Kennedy School's Ash Center. As an honoree, BEITC joins 142 alumni awardees and receives national recognition."This recognition belongs to our entire Coalition, the
More news about: Bears Ears Inter-Tribal Coalition
Nov 25, 2025, 13:49 ET Galaxy Data Centers appoints Ash Roberts as Vice President, Commercial, to head up next phase of growth
started in January with the acquisition of the Redhill Data Centre in Greater London, the leadership team has bolstered its UK operations by appointing Ash Roberts as Vice President, Commercial. An experienced technology sales leader, joining Galaxy is a natural next step for Roberts who has achieved results
More news about: Galaxy Capital Partners / Jaymie Scotto & Associates, LLC
Nov 25, 2025, 09:29 ET CreatorFi Launches on Aptos with $2M Strategic Backing to Scale Stablecoin Credit for Creators
the growth of the creator economy, a massively successful and fast growing market that has been historically underserved by traditional lenders," said Ash Pampati, SVP, Head of Ecosystem at Aptos Foundation and former Global Head of Go-To-Market for YouTube Music. "This is exactly the kind of real-world,
More news about: CreatorFi
Nov 25, 2025, 08:36 ET Menarini Group 宣佈將於第 67 屆美國血液學會年會暨展覽會 (67th American Society of Hematology Annual Meeting and Exposition) 發表 ELZONRIS® (tagraxofusp-erzs) 最新數據
Group（下稱「Menarini」），作為國際領先的製藥與診斷企業，與其全資附屬公司 Stemline Therapeutics, Inc.（下稱「Stemline」）今日宣佈，公司將於 12月6日至9日在美國佛羅里達州奧蘭多舉行的美國血液學會 (American Society of Hematology; ASH) 年會暨展覽會上，發表關於 ELZONRIS® (tagraxofusp-erzs) 的最新數據。
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 08:00 ET Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
announced it will exhibit at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition, taking place December 6–9, 2025, in Orlando, Florida. The Citius Oncology team will be located at Booth #265 in the ASH Exhibit Hall to discuss LYMPHIR (denileukin diftitox-cxdl), its
More news about: Citius Oncology, Inc.
Nov 25, 2025, 05:07 ET Menarini Group anuncia nuevos datos sobre ELZONRIS ® (tagraxofusp-erzs) que se presentarán en la 67ª Reunión y Exposición Anual de la Sociedad Americana de Hematología
compañía presentará nuevos datos relacionados con ELZONRIS ® (tagraxofusp-erzs) en la Reunión y Exposición Anual de la Sociedad Americana de Hematología (ASH) en Orlando, del 6 al 9 de diciembre .
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 05:04 ET Menarini Group anuncia novos dados sobre ELZONRIS® (tagraxofusp-erzs) a serem apresentados na 67ª Reunião e Exposição Anual da Sociedade Americana de Hematologia
a empresa apresentará novos dados relacionados ao ELZONRIS ® (tagraxofusp-erzs) na Reunião e Exposição Anual da Sociedade Americana de Hematologia (ASH) em Orlando, de 6 a 9 de dezembro .
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 04:53 ET Menarini Group anuncia nuevos datos sobre ELZONRIS® (tagraxofusp-erzs)
presentará nuevos datos relacionados con ELZONRIS® (tagraxofusp-erzs) en la Reunión y Exposición Anual de la Sociedad Estadounidense de Hematología (ASH) en Orlando, del 6 al 9 de diciembre.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 04:44 ET 메나리니 그룹, 제67회 미국혈액학회 연례 학술대회에서 ELZONRIS®(tagraxofusp-erzs) 관련 신규 데이터 발표
12월 6일부터 9일까지 올랜도에서 열리는 미국혈액학회(American Society of Hematology, ASH) 연례 학술대회에서 ELZONRIS® (tagraxofusp-erzs) 관련 신규 데이터를 발표한다고 밝혔다.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 24, 2025, 16:52 ET Menarini Group gibt neue Daten zu ELZONRIS® (Tagraxofusp-erzs) bekannt, die auf der 67. Jahrestagung und Ausstellung der American Society of Hematology vorgestellt werden
heute bekannt, dass das Unternehmen neue Daten zu ELZONRIS® (Tagraxofusp-erzs) auf der Jahrestagung und Ausstellung der American Society of Hematology (ASH) in Orlando vom 6. bis 9. Dezember präsentieren wirdth.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 24, 2025, 16:44 ET Menarini Group annonce de nouvelles données sur ELZONRIS® (tagraxofusp-erzs) qui seront présentées lors de la 67e réunion annuelle de l'American Society of Hematology
présentera de nouvelles données relatives à ELZONRIS® (tagraxofusp-erzs) lors de la réunion annuelle et de l'exposition de l'American Society of Hematology (ASH) à Orlando, du 6 au 9 décembreth.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 24, 2025, 12:00 ET Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting
featured as a late-breaking oral presentationBoth BRUIN CLL-314 and BRUIN CLL-313 were selected to be part of the official ASH press programINDIANAPOLIS, Nov. 24, 2025 /PRNewswire/ -- Eli Lilly
More news about: Eli Lilly and Company
Nov 24, 2025, 10:27 ET Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
cancer patients, today announced that the company will present new data related to ELZONRIS® (tagraxofusp-erzs) at the American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, December 6-9th.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 24, 2025, 10:20 ET Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
cancer patients, today announced that the company will present new data related to ELZONRIS® (tagraxofusp-erzs) at the American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, December 6-9th.
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 24, 2025, 07:00 ET BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
stem cell (HSC) mobilization for gene therapies in sickle cell disease (SCD) was accepted for presentation at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition taking place December 6-9, 2025, in Orlando, FL.The 10-subject proof-of-concept study, which was
More news about: BioLineRx Ltd.
Nov 21, 2025, 12:39 ET Hackensack Meridian John Theurer Cancer Center Unveils Research at the 67th American Society of Hematology Annual Meeting
immunotherapies. The depth and breadth of our ASH presentations underscore our mission: to bring transformational science rapidly to the clinic for patients with blood cancers and other serious blood disorders."Highlights of JTCC Research to be presented at ASH 2025 can be found
More news about: Hackensack Meridian John Theurer Cancer Center
Nov 21, 2025, 07:37 ET Les données de PMB-CT01 BAFFR-CAR T de PeproMene Bio ont été sélectionnées pour deux présentations orales lors de la 67e réunion annuelle de l'ASH 2025.
phase 1 en cours sur PMB-CT01 (BAFFR-CAR T) ont été acceptés pour des présentations orales lors du congrès annuel de l'American Society of Hematology (ASH) de 2025.
More news about: PeproMene Bio, Inc.
Nov 21, 2025, 07:20 ET PeproMene BioのPMB-CT01 BAFFR-CAR Tデータ、第67回ASH 2025年次総会の2つの口頭発表に採択
Bioの最高執行責任者（COO）であるHazel Cheng博士は述べています。「これらのデータは、PMB-CT01が再発リスクの高い疾患における重大な未充足ニーズに対処する可能性を浮き彫りにしています。」ASH 2025口頭発表演題タイトル：BAFFR-CAR T細胞は、r/r B細胞リンパ腫において持続的な奏効率と管理可能な毒性を示す…（BAFFR-CAR
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 19:08 ET 페프로민 바이오, BAFFR-CAR T 'PMB-CT01' 데이터, 2025년 ASH 제67차 연례학회 구두 발표 2건 선정
위한 혁신 치료제를 개발하는 임상단계 바이오테크 기업 페프로민 바이오(PeproMene Bio, Inc.)가 자사 PMB-CT01(BAFFR-CAR T) 임상 1상 연구 초록 두 건이 2025년 미국혈액학회(American Society of Hematology, ASH) 연례학회에서 구두 발표로 채택됐다고 밝혔다.
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 16:25 ET Daten zu PMB-CT01 BAFFR-CAR T von PeproMene Bio für zwei mündliche Präsentationen auf der 67. Jahrestagung 2025 von ASH ausgewählt
seinen laufenden Phase-1-Studien zu PMB-CT01 (BAFFR-CAR T) für mündliche Präsentationen auf der Jahrestagung 2025 der American Society of Hematology (ASH) angenommen wurden.
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 16:20 ET Los datos del estudio PMB-CT01 BAFFR-CAR T de PeproMene Bio seleccionados para dos ponencias en la ASH 2025
- Los datos del estudio PMB-CT01 BAFFR-CAR T de PeproMene Bio fueron seleccionados para dos ponencias en la 67ª Reunión Anual de la ASH 2025 IRVINE, Calif., 20
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted for oral presentations at the 2025 American Society of Hematology (ASH) Annual Meeting.
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted for oral presentations at the 2025 American Society of Hematology (ASH) Annual Meeting.
More news about: PeproMene Bio, Inc.